The company's consolidated revenue from operation fell by 42.86 per cent to Rs 798 crore for the March quarter
In spite of the Covid-induced economic slowdown, the Tripura Gramin Bank (TGB), one of the leading banks among the 43 Regional Rural Banks (RRBs) in India
The value of new business (VNB) margin for 2022-23 was 16.2 per cent (net) as compared to 15.1 per cent (net) in the previous year
Sequentially, the company's quarterly net profit rose 2.4%. In the previous quarter, profit after tax had stood at Rs 1,746.10 crore
Its revenue from operations slipped 15.86 per cent to Rs 1,573.25 crore against Rs 1,869.85 crore in the corresponding quarter last fiscal
For FY23, the profit stood at Rs 36,397.40 crore as compared to Rs 4,043.12 crore for the previous financial year
Revenue from operations stood at Rs 5,649.65 cr in Q4FY23, rising by 26.15% from Rs 4,478.61 cr in Q4 of the previous fiscal
This came as the firm witnessed a demand slump for its fashion business, and expenses surged due to growing cost of materials, employee costs and other expenses
On a standalone basis, net profit of Rs 94.75 crore for the year ended March 2023 was seen up 101 per cent over the Rs 46.91 crore for the corresponding period of the previous year
Consolidated revenue from operations increased by 17.6 per cent YoY to Rs 403.2 crore in FY23
According to a company statement, revenue from operations for the fourth quarter under consideration stood at Rs 234.73 crore as against Rs 219.67 crore in the year-ago period
Revenue of the company stood at Rs 762 crore in the fourth quarter of FY23 as against Rs 625 crore in the same period of FY22, JB Pharma said in a statement
The company has a strong pipeline of ongoing projects of around 20 million square feet and upcoming projects of 7.5 million square feet, she said
The company received an order worth Rs 1,262 crore in the fourth quarter, which was higher than Rs 1,043.6 crore in the year-ago period
Nykaa's Ebitda rose 84 per cent to Rs 70.6 crore during the quarter
The company reported consolidated profit after tax at 3.49 billion rupees ($42.7 million) in the three months ended March 31, compared to 2.16 billion rupees a year earlier
During the quarter, the company's revenue from operations rose to Rs 19,995 crore from Rs 18,969 crore in Q4FY22
While Group revenue was impacted due to the softness in the device market, revenue from non-PC businesses reached a fiscal year high of nearly 40%
Total income rose to Rs 1,656 crore in the fourth quarter over Rs 1,384 crore in the fourth quarter of 2021-22 fiscal, Fortis Healthcare said in a statement
Dixon Technologies (India) Ltd on Tuesday reported a 27.7 per cent rise in consolidated net profit at Rs 80.62 crore for the fourth quarter ended March 31, 2023.